Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use
The combined entity will leverage its complementary strengths to deliver unparalleled solutions in protein purification and stabilization
Automated parallel capillary electrophoresis system simplifies protein analysis
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
In-house wet testing with live Omicron virus demonstrated that the Antigen test detects the Omicron variant with comparable sensitivity to other variants
Subscribe To Our Newsletter & Stay Updated